Clinical Trial Update: A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 [Phase 1]

View source ↗

Summary

The document describes a Phase 1, parallel-group, double-blind, placebo-controlled study to assess interactions between single oral doses of reserpine and intra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amphetamine-related Disorders

Drugs mentioned

• Methamphetamine (methamphetamine)
• Reserpine (reserpine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Amphetamine-Related Disorders | Phase 1 | Status: UNKNOWN